Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / A••• S••••• C•••••• L••

A••• S••••• C•••••• L••

Buyout firm · probableLower middle marketLondona•••••••••SEC exempt reporting adviser

A••• S••••• is a frontier-markets private equity firm investing flexible & strategic capital in consumer & healthcare opportunities across African markets.

Classification
Class
Buyout firmprobable, confidence 80%
Basis
own website statement
Size band
Lower middle marketdefined by: proxy: $0.06bn Private Equity Fund GAV on the Form ADV filed 2024-05-30
Classification history (2)
  1. Sep 18, 2026
    Buyout firm (probable, 80%, cls-pe-2)
    own website statement
    “Prior to founding A••• S•••••, A••••• spent nearly five years with the Duet Group as the Managing Director of the firm’s African Private Equity platform, investing nearly US$200m across Sub-Saharan Africa.”
    altasemper.com
  2. Sep 13, 2026
    Buyout firm (confirmed, 85%, cls-pe-1)
    R6: 2 of 2 distinct vehicles are sworn Private Equity Funds; 2 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
Adviser type
exempt reporting adviser
Form ADV filings
Jul 6, 2020 to May 30, 2024
RAUM
unknownregulatory assets under management of the adviser; not dry powder, not a fund size
PE funds, latest filing
2
PE fund GAV, latest filing
$58.6Mreported gross assets (Form ADV), not fund size
All private fund GAV
$58.6Mevery private fund type, latest filing
2024 PE fund GAV
$58.6Msum over funds typed Private Equity Fund with a 2024 or later as-of date
PE share of funds, lifetime
100%
Fund type mix
filed 2024-05-30, latest gav Private Equity Fund $58.6M, latest counts Private Equity Fund 2, lifetime distinct Private Equity Fund 2
Employees
unknown
Headquarters
London, United Kingdom
Office address
35 BERKELEY SQUARE, London, W1J 5BF
Business phone
0207 100 0670
Stated criteria beside observed behaviour
4 observed deals
Stated by the firm
Sectors
healthcare, technology, financial services, infrastructure, education, consumer, life sciences
Geography
United States, Europe, Global
Revenue
not stated or not yet read
EBITDA
not stated or not yet read
Enterprise value
not stated or not yet read
Equity check
not stated or not yet read
Control
control,majority
Thesis
We back market leading businesses in promising growth markets where we can enable operational impact
Observed from deals on record
roles
unknown 4
period
to 2026-01-01, from 2017-01-01, undated holdings 1, dated observations 3
window
last unknown, first unknown
control
unknown 4
companies
4
geography
investments
4
seller kinds
transactions
0
cadence by year
platform add on
add ons 0, platforms 0, add ons per platform unknown
sector known for
0
disclosed value usd
n 0
sector distribution
holding period years
n 0
repeat counterparties
subsector distribution

4 companies on the graph (0 transactions); observed 2017 to 2026

Funds
2 on record
FundVehicleVintageReported gross assets (Form ADV), not fund sizeGAV by yearForm D soldLifecycle
A••• S••••• I•••• F••• I• L•
ADV: Private Equity Fund
buyout or unlabelledunknown$57.9M
as of May 30, 2024
no Form DMature
A••• S••••• I•••••••• L•••••• •••••
ADV: Private Equity Fund
buyout or unlabelledunknown$682,373
as of May 30, 2024
no Form DMature
Team
3 current, 0 former
Portfolio
4 relationships, 0 platforms, 0 add-ons
CompanyRoleStatusInvestedHeldPartnerSource
N••••••• R•••Role unknownunknownJan 1, 2026
year stated on the firm's page
9 monthsunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
M•••••Role unknownunknownJan 1, 2021
year stated on the firm's page
5.7 yearsunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
M•••• P•••••••••Role unknownunknownJan 1, 2017
year stated on the firm's page
9.7 yearsunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
M•••• P•••••••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
Transactions
0 on record
No transaction naming this firm has been collected yet. The deal tape is read from SEC filings and cited announcements.
Placement agents, lenders, advisers and co-investors
0 relationships
No counterparty collected yet. These are counted from transactions that name both this firm and the other party, and from placement agents on this firm’s funds.
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
3 most recent
  1. Jun 9, 2026
    A••• S••••• C•••••• L••: Private Equity Funds on Form ADV 2 (2024 extract) -> 3 (roster 2026-09-01)
    Pe fund count changedFactSEC Form ADV monthly roster (registered + exempt reporting advisers)
  2. Dec 17, 2022
    mPharma acquires majority stake in HealthPlus
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  3. Jul 6, 2020
    A••• S••••• C•••••• L•• first filed Form ADV in the extract (ERA)
    First Form ADV filingFactSEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)